Paul W. Hawran, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 10,000 shares at $3.50 ($35K) on 2009-11-12, disclosed to the SEC on 2009-11-12.
Open-market purchase of $35k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CYTX | BUY | 2010-05-19 | $24K | — | Filing → |
| CYTX | BUY | 2009-11-25 | $25K | — | Filing → |
| CYTX | BUY | 2009-11-24 | $24K | — | Filing → |